MTP 3631

a thiopyranopyrimidine derivative; structure given in first source

Also Known As:

7,8-dihydro-4-(3-hydroxypiperidinyl)-2-piperazinyl-6H-thiopyrano(3,2-d)pyrimidine-5,5-dioxide; MTP-3631; 3-Piperidinol, 1-(7,8-dihydro-2-(1-piperazinyl)-6H-thiopyrano(3,2-d)pyrimidin-4-yl)-, S,S-dioxide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - MTP 3631: 1
  - Piperazines: 26
    - MTP 3631: 1

Related Diseases

1.	Glucose Intolerance 01/01/1992 - "MTP-3631 markedly decreased basal blood glucose and improved glucose intolerance in genetically diabetic C57BL/6J ob/ob mice, which was not affected by tolbutamide. "

Related Drugs and Biologics

1.	Tolbutamide (Orinase)
2.	Blood Glucose (Blood Sugar)